Present and future therapeutic strategies for melioidosis and glanders. - Wikidata - awgldk - TriplyDB

Present and future therapeutic strategies for melioidosis and glanders.

Present and future therapeutic strategies for melioidosis and glanders.

http://www.wikidata.org/entity/Q33797791

about

Involvement of the efflux pumps in chloramphenicol selected strains of Burkholderia thailandensis: proteomic and mechanistic evidence Animal models for Francisella tularensis and Burkholderia species: scientific and regulatory gaps toward approval of antibiotics under the FDA Animal Rule Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens Prophylactic application of CpG oligonucleotides augments the early host response and confers protection in acute melioidosis Leveraging structure determination with fragment screening for infectious disease drug targets: MECP synthase from Burkholderia pseudomallei Nasal Acai polysaccharides potentiate innate immunity to protect against pulmonary Francisella tularensis and Burkholderia pseudomallei Infections Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.Comparing in vitro and in vivo virulence phenotypes of Burkholderia pseudomallei type G strains.Melioidosis: Clinical impact and public health threat in the tropics.DBSecSys: a database of Burkholderia mallei secretion systems.Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei.Genotyping of Burkholderia mallei from an outbreak of glanders in Bahrain suggests multiple introduction events Deletion mutations conferring substrate spectrum extension in the class A β-lactamase.Rapid identification of Burkholderia mallei and Burkholderia pseudomallei by intact cell Matrix-assisted Laser Desorption/Ionisation mass spectrometric typing.Effectiveness of an antimicrobial treatment scheme in a confined glanders outbreak Treatment and prophylaxis of melioidosis Novel Burkholderia mallei virulence factors linked to specific host-pathogen protein interactions.Low-dose exposure of C57BL/6 mice to burkholderia pseudomallei mimics chronic human melioidosis Mining host-pathogen protein interactions to characterize Burkholderia mallei infectivity mechanisms.In vivo Bioluminescence Imaging of Burkholderia mallei Respiratory Infection and Treatment in the Mouse Model.Nitric oxide from IFNγ-primed macrophages modulates the antimicrobial activity of β-lactams against the intracellular pathogens Burkholderia pseudomallei and Nontyphoidal Salmonella T346Hunter: a novel web-based tool for the prediction of type III, type IV and type VI secretion systems in bacterial genomes.Antibacterial and Antifungal Activity of ZnO Containing Glasses Burkholderia vaccines: are we moving forward?Nematode Peptides with Host-Directed Anti-inflammatory Activity Rescue Caenorhabditis elegans from a Burkholderia pseudomallei Infection.Monitoring Therapeutic Treatments against Burkholderia Infections Using Imaging Techniques Natural infection of Burkholderia pseudomallei in an imported pigtail macaque (Macaca nemestrina) and management of the exposed colony.Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis.Glanders: an overview of infection in humans.Deciphering minimal antigenic epitopes associated with Burkholderia pseudomallei and Burkholderia mallei lipopolysaccharide O-antigens.A reverse-phase protein microarray-based screen identifies host signaling dynamics upon Burkholderia spp. infection.AFN-1252 is a potent inhibitor of enoyl-ACP reductase from Burkholderia pseudomallei--Crystal structure, mode of action, and biological activity.Pathogenesis of percutaneous infection of goats with Burkholderia pseudomallei: clinical, pathologic, and immunological responses in chronic melioidosis.Melioidosis in a returning traveller.When it comes to drug discovery not all Gram-negative bacterial biodefence pathogens are created equal: Burkholderia pseudomallei is different.Raman spectroscopic detection and identification of Burkholderia mallei and Burkholderia pseudomallei in feedstuff.Use of Immunohistochemistry to Demonstrate In Vivo Expression of the Burkholderia mallei Virulence Factor BpaB During Experimental Glanders.Melioidosis: where do we stand in the development of an effective vaccine?Melioidosis in Mexico, Central America, and the Caribbean.Evaluating New Compounds to Treat Infections

P2860

Q21089981-4FB79374-18B5-4D1B-A5D1-E4EC9F90B480 Q26859041-36688AD2-2D58-41C6-9A48-7828A4AD5A5B Q27011190-FC196138-FF7B-482E-976D-B52C428FAC89 Q27305350-329AB033-E6C1-403B-92F6-53AE2C184A11 Q27667103-E8D63B9F-21FC-44A6-9BD0-3428140901C0 Q28731282-AE9A1914-C118-4895-87E7-F1CA3DDE5FEB Q30279061-74A1535C-27F6-4F5D-8A8D-DB4557092F10 Q33570950-487FA291-7F29-4556-BA9A-378A6F11BADB Q33663333-42321E76-726A-4F41-8AB2-2F83853FF977 Q33955395-7797426F-32E0-4977-8C56-1CD137AC7F5D Q34243707-25DA7C80-8056-45FF-9505-8999874DD74C Q34256717-DA211F4E-811D-4598-B781-5E016F04E376 Q34299058-3D462893-F28E-40AC-9AF5-E48183573FB2 Q34436824-39B2EE51-441E-4D45-87AE-BED651898890 Q34470340-7578BBFF-2324-4724-A95A-7C434F0E96DE Q34538191-B8520DDE-3786-4CF3-9D1D-465EB7F007BB Q34783879-1C65A9BD-808C-431D-920B-461B1775AD4F Q35070115-88B44CE3-ED84-47D0-8083-2C4095F1112A Q35147602-08CB3BCB-483A-4DF8-AAE8-E6EA9C29C8A1 Q35182600-7FD73798-3C1E-4674-A595-7D845FEE2578 Q35224538-8C3F7021-1790-4058-ADF2-6A3D55D82B59 Q35600169-AC50291F-5F3F-4503-A037-C4282900BE61 Q35731321-1AAA41DF-23E4-4EB9-9604-96044CFAB800 Q36587103-D7E082CD-D2B7-4C82-AFE3-5D84FBBF6370 Q37248305-1637F9C2-8A7C-43E4-8A80-66612A948110 Q37384332-8E08A8CA-6B2D-4B43-8107-8853BB620AB1 Q37401040-A3552760-0F9E-4382-9A09-D5DAC9D58247 Q38066577-AE52E325-4123-42A8-B9E9-056BEDF1FF1C Q38134214-D909688A-6DA4-4CC8-B71F-F915BB9B430D Q38287677-DA86BFDF-A3C2-424B-868E-91E57B90DD46 Q38973213-853AE3AE-1ACE-47F6-B6D5-4C4C0BCA2D4A Q39383809-64B00AE8-E520-4EB9-BE95-F6167A9E0A87 Q40216703-7794530E-81CD-4459-A144-4AB6E3A620CF Q40250505-4F53FBA6-FE8F-4486-BF8C-BF0EC451AC71 Q41760749-1B2725A1-1B4F-4756-A202-AC8C7992F1E2 Q42212921-6B95BBAF-41E2-4A67-8DB2-0FC72DA09ED7 Q47395188-7602F8F8-DC3C-4455-8091-A56D365F7E35 Q48144660-E0F96284-B806-40BC-B456-39D46BFCE151 Q55085710-0EB372C9-AF1F-4F6F-9476-45D9C40FB9D9 Q56375673-3025048B-0B4D-4635-B6CD-C9EA4479A98B

P2860

Present and future therapeutic strategies for melioidosis and glanders.

http://www.wikidata.org/entity/Q33797791

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Present and future therapeutic strategies for melioidosis and glanders.

@ast

Present and future therapeutic strategies for melioidosis and glanders.

@en

type

label

Present and future therapeutic strategies for melioidosis and glanders.

@ast

Present and future therapeutic strategies for melioidosis and glanders.

@en

prefLabel

Present and future therapeutic strategies for melioidosis and glanders.

@ast

Present and future therapeutic strategies for melioidosis and glanders.

@en

P1433

Q33797791-2A22DB68-CD42-4F3D-A0FC-B32FE1F753F7

P1476

Q33797791-0ECA7D50-E6A8-45D9-9094-C70E91BFD459

P2093

Q33797791-00444386-A05D-4AC5-B1CD-D6C518D2EA36

Q33797791-02C63F3B-5352-4F93-8A00-598FE3EB2902

Q33797791-446698D9-CDA4-4822-ACE1-B1771A4A464C

Q33797791-B19A97DE-E911-43C7-BDA6-3B9D55B27359

P2860

Q33797791-0085F2CE-8255-405E-89FB-003DAD435256

Q33797791-010673F1-BA1A-433E-BA1E-911577617703

Q33797791-04640E83-89B7-4755-B512-E4142BE5AF3D

Q33797791-0E965B24-B116-47D0-8713-B35897E3A1D0

Q33797791-1135B478-89BC-4B3E-91E5-D1F5FE6A3836

Q33797791-13923548-C2C4-4273-9C0F-D4BEF5B46A0F

Q33797791-1916795B-9D56-4BD7-AF0D-489C1B3EE42C

Q33797791-19BF6050-903A-4B8B-8CC9-DD3274FE9CBB

Q33797791-19CD5061-53D5-47B8-BCBC-0ED5BF47D5E0

Q33797791-1D94C8E8-9C14-4DEA-80F6-532C9BAEC30A

P304

Q33797791-A69AEA80-E307-47F0-A3E4-319E6F059252

P31

Q33797791-F18F4A39-362C-4531-B5C0-4AAD7D99E0A0

P356

Q33797791-9ABDAD4B-C47B-4352-A380-CFEF0B8639E5

P433

Q33797791-061583F1-0EA7-4342-8303-F5050D2F4085

P478

Q33797791-868EA838-6881-4841-955D-F7036D8442AB

P577

Q33797791-8B117F76-7A19-4263-964F-F00D54781660

P5875

Q33797791-4488221C-C38B-4C17-BD4A-645C038C7F27

P698

Q33797791-9985A737-0632-4C5C-B781-04EDB5A600CA

P921

Q33797791-67CAA5FD-10B3-45F4-80F7-6A0E81F4AAD1

P932

Q33797791-06C1CCE7-BD79-4766-92E6-624100BCFC2F

P356

P1433

Expert Review of Anti-infective Therapy

P1476

Present and future therapeutic strategies for melioidosis and glanders.

@en

P2093

Alfredo G Torres

http://www.w3.org/2001/XMLSchema#string

D Mark Estes

http://www.w3.org/2001/XMLSchema#string

Herbert P Schweizer

http://www.w3.org/2001/XMLSchema#string

Steven W Dow

http://www.w3.org/2001/XMLSchema#string

P2860

Structural flexibility in the Burkholderia mallei genome

Melioidosis: epidemiology, pathophysiology, and management.

Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence

Type III protein secretion systems in bacterial pathogens of animals and plants

Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei

Outcomes of patients with melioidosis treated with meropenem

Intensity of rainfall and severity of melioidosis, Australia

Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei

Biology and clinical relevance of granulysin

Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis

P304

325-338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERI.10.4

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41654829

http://www.w3.org/2001/XMLSchema#string

P698

20192686

http://www.w3.org/2001/XMLSchema#string

P921

P932

2856610

http://www.w3.org/2001/XMLSchema#string